Status:
RECRUITING
Head and Neck Cancer Patient Symptom and Oncologic Outcomes
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Lymphedema of the Head and Neck
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial investigates a new approach using a mobile three-dimensional (3D) scanning application for volumetric measurement of the head and neck region in patients with head and neck lymphedema. Lymp...
Detailed Description
PRIMARY OBJECTIVES: I. To develop a specialized and mobile 3D surface scanning application to assess and monitor head and neck lymphedema. II. To confirm optimal positioning when volumetrically asse...
Eligibility Criteria
Inclusion
- Patients with pathologies leading to head and neck lymphedema
- Individuals with minimal or no facial hair
- Patients of sound mentation, who are able to execute informed decision-making
Exclusion
- Any health conditions or history of non-compliance that affect the study will preclude study participation
Key Trial Info
Start Date :
March 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05243069
Start Date
March 31 2023
End Date
December 31 2028
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210